Literature DB >> 18060995

Status of the epidemiology of atrial fibrillation.

William B Kannel1, Emelia J Benjamin.   

Abstract

Atrial fibrillation (AF), an increasingly common dysrhythmia, is responsible for substantial morbidity and mortality. Currently in the United States, approximately 2.3 million people are diagnosed with AF and, based on the census, this number may rise to 5.6 million by 2050. Risk factors for AF include advancing age and cardiovascular disease and its risk factors. The chief hazard of AF is embolic stroke, which is increased four- to fivefold, assuming great importance in advanced age when it becomes a dominant factor. AF is associated with about a doubling of mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18060995      PMCID: PMC2245891          DOI: 10.1016/j.mcna.2007.09.002

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  88 in total

1.  The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk.

Authors:  Pamela S Douglas
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.

Authors:  J Krieger; L Laks; I Wilcox; R R Grunstein; L J Costas; J G McDougall; C E Sullivan
Journal:  Clin Sci (Lond)       Date:  1989-10       Impact factor: 6.124

3.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

Authors:  Karin S Coyne; Clark Paramore; Susan Grandy; Marco Mercader; Matthew Reynolds; Peter Zimetbaum
Journal:  Value Health       Date:  2006 Sep-Oct       Impact factor: 5.725

4.  Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996.

Authors:  S Stewart; K MacIntyre; M M MacLeod; A E Bailey; S Capewell; J J McMurray
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

5.  Atrial and ventricular arrhythmias in asymptomatic active elderly subjects: correlation with left atrial size and left ventricular mass.

Authors:  D E Manyari; C Patterson; D Johnson; L Melendez; W J Kostuk; R D Cape
Journal:  Am Heart J       Date:  1990-05       Impact factor: 4.749

6.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

7.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

8.  Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.

Authors:  C J Ostgren; J Merlo; L Råstam; U Lindblad
Journal:  Diabetes Obes Metab       Date:  2004-09       Impact factor: 6.577

9.  Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study.

Authors:  M C Kanter; C H Tegeler; L A Pearce; J Weinberger; W M Feinberg; D C Anderson; C R Gomez; J F Rothrock; C M Helgason; R G Hart
Journal:  Arch Intern Med       Date:  1994-06-27

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  86 in total

1.  Analysis of electrical and mechanical left atrial properties in patients with persistent atrial fibrillation.

Authors:  Anna Degiovanni; Miriam Bortnik; Gabriele Dell'Era; Virginia Bolzani; Eraldo Occhetta; Giorgio Bellomo; Paolo Marino
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-29       Impact factor: 2.357

2.  Effect of obesity on p-wave parameters in a Chinese population.

Authors:  Tong Liu; Zili Fu; Panagiotis Korantzopoulos; Xiaowei Zhang; Shaohua Wang; Guangping Li
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

3.  Calcium-activated potassium current: a novel ion channel candidate in atrial fibrillation.

Authors:  Stanley Nattel
Journal:  J Physiol       Date:  2009-04-01       Impact factor: 5.182

4.  [Thromboembolism prophylaxis in old age].

Authors:  Gabriele Röhrig; Gerald Kolb
Journal:  Z Gerontol Geriatr       Date:  2018-04-05       Impact factor: 1.281

5.  Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Elsayed Z Soliman; Faye Lopez; Wesley T O'Neal; Lin Y Chen; Lindsay Bengtson; Zhu-Ming Zhang; Laura Loehr; Mary Cushman; Alvaro Alonso
Journal:  Circulation       Date:  2015-04-27       Impact factor: 29.690

6.  Acute regional left atrial ischemia causes acceleration of atrial drivers during atrial fibrillation.

Authors:  Masatoshi Yamazaki; Uma Mahesh R Avula; Krishna Bandaru; Auras Atreya; Venkata Subbarao C Boppana; Haruo Honjo; Itsuo Kodama; Kaichiro Kamiya; Jérôme Kalifa
Journal:  Heart Rhythm       Date:  2013-02-21       Impact factor: 6.343

7.  Early life predictors of atrial fibrillation-related mortality: evidence from the health and retirement study.

Authors:  M Maria Glymour; Emelia J Benjamin; Anna Kosheleva; Paola Gilsanz; Lesley H Curtis; Kristen K Patton
Journal:  Health Place       Date:  2013-02-04       Impact factor: 4.078

Review 8.  Sex Differences in Atrial Fibrillation-Update on Risk Assessment, Treatment, and Long-Term Risk.

Authors:  Charlotte J Bai; Nidhi Madan; Shaza Alshahrani; Neelum T Aggarwal; Annabelle Santos Volgman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27

9.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

Review 10.  Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation.

Authors:  Gerald V Naccarelli; Frank Peacock
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.